The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Amicus Therapeutics, Inc(NASDAQ:FOLD) 
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for people living with rare metabolic diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed dia...
Website: http://www.amicusrx.com
Founded: 2002
Full Time Employees: 584
Sector: Healthcare
Industry: Biotechnology
Amicus Therapeutics Days Payable Outstanding ttm (DPO)
Amicus Therapeutics Days Receivable Outstanding ttm (DSO)
Amicus Therapeutics Days Inventory Outstanding ttm (DIO)
Amicus Therapeutics Op Cashflow Per Share ttm
Amicus Therapeutics Free Cashflow Per Share ttm
Amicus Therapeutics Cash Per Share ttm
Amicus Therapeutics P/S ratio ttm
Amicus Therapeutics (GAAP) P/E ratio ttm
Amicus Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.